NRNP 6552 Week 7 Discussion: Health Conditions and Implications for Women

Walden University NRNP 6552 Advanced Nurse Practice in Reproductive Health Care

NRNP 6552 Week 7 Discussion

Some health issues, including heart disease, depression, and autoimmune disease, present more frequently in women than in men. Others, including ovarian cancer and pregnancy issues, are obviously exclusive to the female population. Nurse practitioners focused on women’s healthcare become well-versed in these health issues and apply their expertise to helping to screen for and offer care for patients with these conditions. NRNP 6552 Week 7 Discussion.

For this Discussion, you will select a specific women’s health issue. You will research this issue, and share common symptoms, recommended diagnostic tests, and common treatments.

To prepare:

  • Review the Learning Resources for this week and consider the different types of women’s health issues. NRNP 6552 Week 7 Discussion.
  • Choose one of the women’s health issues from the following list and once you have selected an issue, search the Walden Library and/or the Internet regarding the health issue symptoms, diagnostic tests, and common treatments:
    • Osteoporosis
    • Bladder Issues
    • Pre-diabetes
    • Thyroid
    • Hypertension
    • Seizure Disorders
    • Psychiatric Disorders

Part 1: By Day 3

Based on your chosen issue, post a description and explanation of common symptoms, recommended diagnostic tests, and common treatments. Be specific and provide examples. Use the evidence from your literature search to support your explanation of the woman’s health issue you chose. NRNP 6552 Week 7 Discussion.

Part 2: By Day 5

Next, based on the one women’s health issue you picked listed below, post your responses to the following questions that correspond to your women’s health issue. NRNP 6552 Week 7 Discussion.

  • Osteoporosis – What are your options for primary prevention? How would you educate someone on the treatment?
  • Bladder Issues – What exactly are the symptoms? What about Interstitial cystitis (IC) and pelvic pain?
  • Thyroid – What symptoms occur in women? What can you discern from that? What about infertility?
  • Pre-diabetes – Are there menstrual irregularities? What types of medication are they taking? What about pregnancy plans?
  • Hypertension – What medications are appropriate for a woman of reproductive age? Should you counsel the woman on appropriate dieting?
  • Seizure Disorders – What special implications do you need to consider in this population?
  • Psychiatric Disorders – Specify the types of disorders, i.e., anxiety/depression/substance abuse/eating disorders. NRNP 6552 Week 7 Discussion.

Read a selection of your colleagues’ responses.

By Day 7

Respond to at least two of your colleagues’ posts on two different days and provide additional insight that might be useful and appropriate for the issue addressed. Use your learning resources and/or evidence from the literature to support your position. NRNP 6552 Week 7 Discussion.

Note: For this Discussion, you are required to complete your initial post before you can view and respond to your colleagues’ postings. Begin by clicking on the “Post to Discussion Question” link and selecting “Create Thread” to complete your initial post. Remember, once you click on Submit, you cannot delete or edit your posts, and you cannot post anonymously. Please check your post carefully before clicking on Submit!

Submission and Grading Information

Grading Criteria

To access your rubric:


Health Conditions and Implications for Women

Osteoporosis is a condition that causes an individual’s bone to weaken and become more fragile. The condition affects women more than men due to women’s hormonal changes during menopause, which increasingly affects their bone density. In addition, osteoporosis is more prevalent in women during menopause due to decreased estrogen levels, which are crucial for healthy bones. The discussion will address osteoporosis in women’s common symptoms, recommended diagnostic tests, and common treatment.

Common Symptoms

Osteoporosis’s early stages have no definite symptoms. However, after osteoporosis has weakened one’s bones, the main signs and symptoms include developing a stooped posture, height loss over time, abnormal bone breakages, and back pain resulting from collapsed or fractured vertebra (Butscheidt et al., 2021). 

Recommended Diagnostic Tests

The main diagnostic tests for osteoporosis include the dual-energy x-ray absorptiometry (DEXA) scan, blood tests, and vertebral imaging. The DEXA scan acts like a gold standard for osteoporosis diagnosis since it helps clinicians measure bone density due to its receptive characteristics in bone density changes in osteoporosis (Matzkin et al., 2019). Vertebral imaging engages conventional x-ray on the cervical, thoracic, and lumbar spine to assess vertebral fractures, with vertebral imaging helping identify spinal fractures that may not have any symptoms. On the other hand, blood tests may help in identifying estrogen, Vitamin D, and Calcium levels and deficiencies

Common Treatment

            Treatment recommendations mainly rely on an individual breaking bone risks after gaining the bone information like bone density test. If one is not at high risk, the clinician may decide to modify falls and bone loss risk factors. The first choice of medication for osteoporosis is Bisphosphonates, which include Zoledronic acid (Reclast), an annual intravenous (IV) infusion, and Ibandronate (Boniva), administered as a quarterly IV infusion and a monthly pill (Matzkin et al., 2019). Also, Risedronate (Actonel) is a monthly or weekly pill, and Alendronate (Fosamax) is a weekly pill. However, bisphosphonate may not be the best option for patients with kidney problems, thus needing to be administered with desonumb.

 Part 2

Osteoporosis Primary Prevention

The primary prevention for osteoporosis is ensuring that the disease does not start. Hence, the main intervention will ensure that the patients receive enough calcium from their diet. Therefore, premenopausal women must consume calcium at least 1000mg daily. Calcium can be obtained from beverages and food, including supplements like calcium pills. However, women in postmenopause will need to consume calcium at 1200mg. However, the patient needs to understand that they cannot consume calcium over 2000mg daily due to its side effects. Also, the patient regime needs vitamin D to ensure that the patients maintain proper bone density and formation. According to Leslie and Crandall (2019), experts recommend that postmenopausal women consume Vitamin D  at 20 mg daily while younger women must consume approximately 15mg of Vitamin D daily. The dose is effective since it will help reduce bone fractures and loss in women. Another prevention strategy concerns weight-bearing exercise. Exercise helps in decreasing fracture risks by enhancing bone mass for premenopausal women. Also, Leslie and Crandall (2019) state that exercise is essential in ensuring the women’s body can maintain bone density, especially during menopause. Hence, by engaging in exercise, the women will also improve muscle strength and balance and reduce falls.

Osteoporosis Treatment Education

            Patient education on osteoporosis should mainly focus on preventing and slowing osteoporosis rates. Therefore, using a teaching-back method will be easier to evaluate if the patient understands the amount of calcium and Vitamin D they need daily (Leslie & Crandall, 2019). Also, the patients need to acknowledge osteoporosis risk factors like falls and bone fractures, which will help reduce falls among older women.


Butscheidt, S., Tsourdi, E., Rolvien, T., Delsmann, A., Stürznickel, J., Barvencik, F., … & Oheim, R. (2021). Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations. Bone147, 115911.

Leslie, W. D., & Crandall, C. J. (2019). Population-based osteoporosis primary prevention and screening for quality of care in osteoporosis, current osteoporosis reports. Current Osteoporosis Reports17(6), 483-490.

Matzkin, E. G., DeMaio, M., Charles, J. F., & Franklin, C. C. (2019). Diagnosis and treatment of osteoporosis: what orthopaedic surgeons need to know. JAAOS-Journal of the American Academy of Orthopaedic Surgeons27(20), e902-e912. doi: 10.5435/JAAOS-D-18-00600


NRNP 6552 Week 1  Discussion: Different Roles of the Nurse Practitioner